OpenVSafe by OpenVAERS
Search V-safe

7PG-32457-50881

4 vaccinations 3 coded responses 17 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
802 / CO
Registered
2021-04-26
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-26
    Registered in v-safe
  3. 2021-04-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-05-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-05-08
    Dose 2 — Pfizer-BioNTech
  6. 2021-05-08
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  7. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-05-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-08-07
    Survey response — 3 months, dose 2
    MedDRA: Postpartum disorder, Pre-eclampsia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Postpartum preeclampsia
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  16. 2021-08-07
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-08-10
  18. 2021-12-23
    Dose 3 — Pfizer-BioNTech
  19. 2022-10-06
    Dose 4 — Moderna
  20. 2022-10-06
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  21. 2022-10-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  22. 2022-10-13
    Health check-in — day 7, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  23. 2022-10-20
    Survey response — day 14, dose 4
    MedDRA: Mastitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Mastitis
    MedDRA releases: 2024-11 · check-in free text available
  24. 2023-01-05
    Survey response — 3 months, dose 4
    MedDRA: Influenza — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech
22021-05-08Pfizer-BioNTech
32021-12-23Pfizer-BioNTech No
42022-10-06Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-08-07 Unsuccessful

Free text

Release 9 — 3 months, dose 2

2021-08-07

Symptoms: Postpartum preeclampsia

Release 12 — day 14, dose 4

2022-10-20

Symptoms: Mastitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDInfluenza · · ✓
SDMastitis · · ✓
SDPostpartum disorder ✓ · ✓
SDPre-eclampsia ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release